Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985;20(3):189-92.
doi: 10.1007/BF00205574.

Modulation of natural killer activity by thymosin alpha 1 and interferon

C Favalli, T Jezzi, A Mastino, C Rinaldi-Garaci, C Riccardi, E Garaci

Modulation of natural killer activity by thymosin alpha 1 and interferon

C Favalli et al. Cancer Immunol Immunother. 1985.

Abstract

A single injection of alpha beta-interferon (alpha beta-IFN) (30000 units/mouse), a major biological modifier of natural killer (NK) cytolytic activity, strongly stimulated NK activity in normal mice, as expected, while the same treatment did not statistically alter the NK response in cyclophosphamide (CY)-suppressed animals. We investigated the possibility of thymosin alpha 1 cooperating with alpha beta-IFN in boosting NK activity in CY-suppressed animals. The results show that treatment with thymosin alpha 1 (200 micrograms/kg) for 4 days, followed by a single injection of alpha beta-IFN 24 h before testing, strongly restored NK activity in CY-suppressed mice. Thymosin alpha 1 was, moreover, able to accelerate the recovery rate of NK activity in bone marrow reconstituted murine chimeras. Taken together the data support the concept that the synergic effect between thymosin alpha 1 and alpha beta-IFN could be the result of effects on differentiation of the NK lineage at different levels.

PubMed Disclaimer

References

    1. Bardos P, Bach JF. Modulation of mouse natural killer cell activity by serum thymic factor. Scand J Immunol. 1982;15:321. - PubMed
    1. Bash JA, Woody JN, Neefe JR. NK Cells and other natural effector cells. New York: Academic Press; 1982. Phase I trial of immunomodulatory activities of human leukocyte interferon in advanced cancer patients; p. 1273.
    1. Bloom BR. Interferons and the immune system. Nature. 1980;284:593. - PubMed
    1. Djeu JY, Heinbaugh A, Holden HT, Herberman RB. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol. 1979;122:175. - PubMed
    1. Einhorn S, Blomgren H, Strander H. Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon. Int J Cancer. 1980;26:419. - PubMed

Publication types

LinkOut - more resources